Clinical Trial Update: Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating docetaxel and cisplatin in stage III/IV non-small cell lung cancer was terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-11-25